KEVIN HAMMEL: Open Payments
NPI 1356809230 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$385 in 11 payments from 6 companies in 2025. Trend: 2023 $611 · 2024 $304 · 2025 $385
Food & beverage: $385
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 2 | $148 |
| ABBVIE INC. | 5 | $115 |
| Cipher Pharmaceuticals US LLC | 1 | $55 |
| Inspire Medical Systems, Inc. | 1 | $28 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $21 |
| Philips North America LLC | 1 | $18 |
Products named: DUPIXENT, VRAYLAR, Natroba, INSPIRE, CAPLYTA, Vest Therapy Und.
Industry payments across PA — which companies pay providers there.
